179 studies found for:
Multiple System Atrophy
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
|
||||
| 2 | Completed |
Fluoxetine in Multiple System Atrophy Patients
|
||||
| 3 | Terminated |
Lithium in Multiple System Atrophy
|
||||
| 4 | Active, not recruiting |
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
|
||||
| 5 | Recruiting |
Oligomeric Alpha-synuclein in Multiple System Atrophy
|
||||
| 6 | Recruiting |
Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study
|
||||
| 7 | Completed |
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
|
||||
| 8 | Completed |
Study of Rifampicin in Multiple System Atrophy
|
||||
| 9 | Completed |
Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
|
||||
| 10 | Completed |
Assessment of Ambulatory Polygraphy in the Detection of Sleep Apnea in Multiple System Atrophy (SAMSA)
|
||||
| 11 | Completed |
Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
|
||||
| 12 | Terminated |
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
|
||||
| 13 | Unknown † |
Fipamezole in Neurogenic Orthostatic Hypotension
|
||||
| 14 | Completed |
Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)
|
||||
| 15 | Recruiting |
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
|
||||
| 16 | Completed |
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
|
||||
| 17 | Completed |
Study About Efficacy and Safety to Treat Multi-System-Atrophy
|
||||
| 18 | Recruiting |
Magnetic Resonance Spectroscopy in Autonomic Failure
|
||||
| 19 | Recruiting |
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
|
||||
| 20 | Unknown † |
Diagnostic and Prognostic Biomarkers in Parkinson Disease
|
† Indicates status has not been verified in more than two years
